New Insights into the Roles of RGC-32
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Li L, Bu X, Wang S, Liu Y, Chen C, Zhang W Transl Oncol. 2024; 52:102248.
PMID: 39709718 PMC: 11832949. DOI: 10.1016/j.tranon.2024.102248.
Zhou Q, Tao C, Ge Y, Yuan J, Pan F, Lin X BMC Biol. 2024; 22(1):133.
PMID: 38853238 PMC: 11163722. DOI: 10.1186/s12915-024-01931-z.
Zhang K, Kan H, Mao A, Geng L, Ma X Exp Mol Med. 2021; 53(12):1866-1876.
PMID: 34862465 PMC: 8741768. DOI: 10.1038/s12276-021-00704-w.
References
1.
Vlaicu S, Cudrici C, Ito T, Fosbrink M, Tegla C, Rus V
. Role of response gene to complement 32 in diseases. Arch Immunol Ther Exp (Warsz). 2008; 56(2):115-22.
PMC: 7079747.
DOI: 10.1007/s00005-008-0016-3.
View
2.
Guo S, Philbrick M, An X, Xu M, Wu J
. Response gene to complement 32 (RGC-32) in endothelial cells is induced by glucose and helpful to maintain glucose homeostasis. Int J Clin Exp Med. 2014; 7(9):2541-9.
PMC: 4211757.
View
3.
Cui X, Luan J, Ye J, Chen S
. RGC32 deficiency protects against high-fat diet-induced obesity and insulin resistance in mice. J Endocrinol. 2014; 224(2):127-37.
PMC: 4293277.
DOI: 10.1530/JOE-14-0548.
View
4.
Tanaka T, Takada H, Nomura A, Ohga S, Shibata R, Hara T
. Distinct gene expression patterns of peripheral blood cells in hyper-IgE syndrome. Clin Exp Immunol. 2005; 140(3):524-31.
PMC: 1809394.
DOI: 10.1111/j.1365-2249.2005.02805.x.
View
5.
Tegla C, Cudrici C, Azimzadeh P, Singh A, Trippe 3rd R, Khan A
. Dual role of Response gene to complement-32 in multiple sclerosis. Exp Mol Pathol. 2012; 94(1):17-28.
DOI: 10.1016/j.yexmp.2012.09.005.
View